Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Oct 15, 2023; 15(10): 1796-1806
Published online Oct 15, 2023. doi: 10.4251/wjgo.v15.i10.1796
Published online Oct 15, 2023. doi: 10.4251/wjgo.v15.i10.1796
Table 1 Patient demographics
| Characteristic | Overall (n = 134) | Advent Health (n = 62) | City of Hope (n = 72) |
| Age at diagnosis (yr) | |||
| Mean | 65 | 64 | 65 |
| Median (range) | 64 (33-90) | 63 (44-79) | 66 (33-90) |
| Sex, n (%) | |||
| Male | 101 (75) | 50 (81) | 51 (71) |
| Female | 33 (25) | 12 (19) | 21 (29) |
| BMI, n (%) | |||
| < 18.5 | 4 (3) | 4 (6) | - |
| 18.5-24.9 | 48 (36) | 20 (32) | 28 (39) |
| 25-29.9 | 38 (28) | 14 (23) | 24 (33) |
| ≥ 30 | 34 (25) | 21 (34) | 13 (18) |
| Not reported | 10 (8) | 3 (5) | 7 (10) |
| Race, n (%) | |||
| Asian | 25 (19) | 3 (5) | 22 (31) |
| African-American | 15 (11) | 11 (18) | 4 (6) |
| Native Hawaiian or other Pacific Islander | 1 (1) | - | 1 (1) |
| Caucasian | 83 (62) | 41 (66) | 42 (58) |
| Not reported | 10 (7) | 7 (11) | 3 (4) |
| Ethnicity, n (%) | |||
| Hispanic or Latino | 34 (25) | 16 (26) | 18 (25) |
| Non-Hispanic or Non-Latino | 94 (70) | 45 (73) | 49 (68) |
| Not reported | 6 (5) | 1 (1) | 5 (7) |
- Citation: Li D, Gruber SB, Iyer S, Gupta S, Tejani M. Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States. World J Gastrointest Oncol 2023; 15(10): 1796-1806
- URL: https://www.wjgnet.com/1948-5204/full/v15/i10/1796.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i10.1796